The stock of Omega Diagnostics Group Plc (LON:ODX) is a huge mover today! The stock decreased 0.71% or GBX 0.12 on November 15, hitting GBX 17.5. About 21,576 shares traded hands. Omega Diagnostics Group Plc (LON:ODX) has risen 22.61% since April 18, 2016 and is uptrending. It has outperformed by 18.68% the S&P500.
The move comes after 5 months positive chart setup for the GBX 20.33M company. It was reported on Nov, 15 by Barchart.com. We have GBX 48.65 PT which if reached, will make LON:ODX worth GBX 36.19 million more.
Another recent and important Omega Diagnostics Group Plc (LON:ODX) news was published by Fool.Co.Uk which published an article titled: “Should I Sell Shire plc & Buy Omega Diagnostics Group plc Right Now?” on July 07, 2015.
Omega Diagnostics Group PLC is a medical diagnostics company. The company has a market cap of 20.33 million GBP. The Company’s divisions are Allergy and Autoimmune; Food Intolerance; Infectious/Other, and Corporate. It has a 33.52 P/E ratio. The Company’s product categories include allergy, anemia, autoimmunity, fertility and growth hormones, food intolerance, infectious disease, inflammation, quality control, thyroid hormones and tumor markers.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.